China Pharma Holdings Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 05/15/2026 | 12.92 K | $7.88 K | 100.00% | 0.30% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 11.42 K | $6.97 K | 0.88% | 0.27% |
| CITIGROUP INC | 05/11/2026 | 996 | $608 | 100.00% | 0.02% |
| UBS GROUP AG | 05/05/2026 | 389 | $237 | -24.17% | 0.01% |
| 05/15/2026 | 40 | $24 | 0.00% | 0.00% | |
| DANSKE BANK A/S | 05/12/2026 | 1 | $1 | 0.00% | 0.00% |
| DRW SECURITIES, LLC | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
China Pharma Holdings Inc. institutional Ownership - FAQ's
During the previous two years, 11 institutional investors and hedge funds held shares of China Pharma Holdings Inc.. The most heavily invested institutionals were:
CITADEL ADVISORS LLC: 12,924
RENAISSANCE TECHNOLOGIES LLC: 11,418
CITIGROUP INC: 996
UBS Group AG: 389
DANSKE BANK A/S: 1
DRW Securities, LLC: 0
0.60% of China Pharma Holdings Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 158.36 K shares in the last 24 months. This purchase volume represents approximately $95.02 K in transactions.